1005-2015

class com.aha.ucm.component.cis.TagListPageData=[,docNativeURL=null,docName=UCM_475299,docStatus=RELEASED,dOutDate=null,docSSFileName=UCM_475299_Dyslipidemia-and-Treatments.jsp,docTitle=Dyslipidemia and Treatments,xWebsites=professional,dDocAuthor=stacy.ragsdale,xNextReviewDate=12/09/2015 6:00 AM,xTier1=,xFeaturedItem=No,xElectronicRegistration=No,UserLocale=null,xSubCategory=,dpEvent=null,xComments=AHA Community page for Dyslipidemia and Treatments,NoHttpHeaders=null,UserTimeZone=null,xRegionDefinition=GENERIC_RD_HYBRID_01,xVideoRenditions=,xSnippetItem=,xNotes=,UserDateFormat=null,encodeDocUrl=null,isDocProfileDone=null,xKeywords=,xTier2=,refreshSubMonikers=null,xEditorStepReassignedUsers=null,xLinkTextToDisplay=,dDocAccount=WCM/SOP/SMD,xEndDateTime=null,xClbraAliasList=null,ClientEncoding=null,xCpdIsLocked=0,xUsageRightsDate=null,xModifyDate=06/15/2019 5:12 AM,xTier3=,xEventDate=null,dSubscriptionType=null,xCopyright=No,xPackagedConversions=,dSubscriptionAlias=null,xStorageRule=,dpName=null,xDepartment=Digital Solutions - NC,dStatus=RELEASED,dPublishType=,xCopyrightDetails=,xSubType=63,isDocProfileUsed=null,xWebsiteObjectType=Data File,xWebFlag=,xSeeAlsoLinks=,xClbraUserList=null,xPartitionId=,xCpdIsTemplateEnabled=0,xLinkWebAddress=,xDontShowInListsForWebsites=,xStartDateTime=null,dInDate=06/15/2019 5:08 AM,xWebsiteSection=professional:1365,dDocName=UCM_475299,dpAction=null,dRevLabel=25,dSecurityGroup=AHAMAH-Public,xCategory=,refreshMonikers=null,xDamConversionType=,dDocFormats=null,xAssociatedImage=,dDocType=Hybrid01,xBusinessOwner=Business Owner,xUploadDate=null,xDiscussionCount=0,xMainFlowEntryCriteria=True,xItemInformation=,xUsageRights=,xDiscussionType=N/A,xRecipeTaxonomy=,dSubscriptionID=null,dOriginalName=UCM_475299.xml,xProfileTrigger=Hybrid01,dLocation=,dRevisionID=16,dPublishState=,dReleaseState=Y,xTrashDeleter=null,dMessage=,dWebExtension=xml,dExtension=xml,dProcessingState=Y,xTrashDeleteName=null,dIsCheckedOut=0,xForceFolderSecurity=null,dRevClassID=475299,dIsPrimary=1,dFileSize=8889,dIndexerState=,dFlag1=,xviaAddNewContentService=,dIsWebFormat=0,xCollectionID=null,dRevRank=0,xReadOnly=null,dCheckoutUser=,dFormat=Application/xml,dWorkflowState=,dDocID=1892956,dRendition2=,dRendition1=,xInhibitUpdate=null,dReleaseDate=06/15/2019 5:26 AM,xTrashDeleteLoc=null,dCreateDate=06/15/2019 5:12 AM,xHidden=null,labelTier1=Communities,labelTier2=DyslipidemiaandTreatments,labelTier3=,labelTier4=,mobileNavURL=DEFAULT2_VALUE_FROM_getDataForAdvanceSearch,xContactPhoneNumber=,xContactEmailAddress=,xContactName=,xATGRolesDisciplines=,xPublishDate=12/09/2014 6:00 AM,xRobotParameter=,xCommunities=1005-2015,xMembershipLevel=,rsCalories=null,rsSodium=null,rsRecipeTaxonomy=null,rsServings=null,rsTotalTime=null,rsTotalFat=null,rsTotalCarbs=null,rsFeaturedImage=null,xDisplayComments=

Dyslipidemia and Treatments

Science NewsView All Science News

Science News 2019 Scientific Sessions
11/16/2019 | Science News coverage of selected presentations and interviews from AHA's Scientific Sessions 2019. Nov. 16-18, 2019 in Philadelphia, PA.

ORION-10 Phase III Trial Details
11/10/2019 | Safety and Efficacy of Inclisiran in Patients With ASCVD and Elevated LDL Cholesterol - Results From the Phase 3 ORION-10 Trial

2019 Update to the 2018 Acute Ischemic Stroke Guidelines
10/30/2019 | This guideline update provides up-to-date comprehensive recommendations for the management and treatment of persons with acute arterial i...

Change in Cardiometabolic Risk Factors Associated With Magnitude of Weight Regain 3 Years After a 1-Year Intensive Lifestyle Intervention in Type 2 Diabetes Mellitus: The Look AHEAD Trial
10/09/2019

EPI | LIFESTYLE 2020 Scientific Sessions

Epidemiology and Prevention | Lifestyle and Cardiometabolic Health 2020 Scientific Sessions
March 3–6 2020
Hyatt Regency Phoenix
Phoenix, Arizona

Learn About EPI | Lifestyle 2019

Related Councils

Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB)

The Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) contributes to the mission and objectives of the American Heart Association (AHA) through efforts in the fields of arteriosclerosis, thrombosis and vascular biology. The council advances and coordinates research, addresses prevention, improves methods for diagnosis and treatment, and works actively with other organizations concerned with these issues. The council disseminates reliable information related to these fields through its annual conference, many awards and lectures, and the AHA's journal, Arteriosclerosis, Thrombosis, and Vascular Biology.

Mary Sorci-Thomas, PhD, FAHA
Chair, Council on Arteriosclerosis, Thrombosis and Vascular Biology

Vascular Discovery Scientific Sessions Arteriosclerosis, Thrombosis, and Vascular Biology ATVB Council Awards

Council on Lifestyle and Cardiometabolic Health

The Council on Lifestyle and Cardiometabolic Health promotes the expansion and exchange of knowledge with the ultimate goal of improving cardiovascular health across the lifespan. Our council promotes basic, clinical, epidemiological, and translational science related to nutrition, lipids, obesity, diabetes, physical activity, and behavior change.

Penny M. Kris-Etherton, PhD, RD, FAHA, FASN, FNLA, CLS
Chair, Council on Lifestyle and Cardiometabolic Health

EPI|Lifestyle Scientific Sessions Circulation Lifestyle Council Awards

Council on Clinical Cardiology (CLCD)

The purpose of the Council on Clinical Cardiology (CLCD) is to achieve the objectives of the American Heart Association (AHA) in the field of clinical cardiology, to promote excellence in clinical care and to foster the professional development and education of clinical cardiologists. Through council-sponsored symposia, panels and scientific conferences, members can access new developments in the field and interpret and promote clinical cardiology to professional and lay audiences.

Eldrin Lewis, MD, MPH, FAHA, FACC
Chair, Council on Clinical Cardiology

Scientific Sessions Circulation CLCD Council Awards